Differentiation of Glioblastoma Multiforme and Single Brain Metastasis by Peak Height and Percentage of Signal Intensity Recovery Derived from Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging

References

1. ↵
   Davis FG, McCarthy BJ, Berger MS. Centralized databases available for describing primary brain tumor incidence, survival, and treatment: Central Brain Tumor Registry of the United States; Surveillance, Epidemiology, and End Results; and National Cancer Data Base. Neuro-oncol 1999;1:205–11

   Abstract/FREE Full Text
2. ↵
   Surawicz TS, McCarthy BJ, Kupelian V, et al. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990–1994. Neuro-oncol 1999;1:14–25

   Abstract/FREE Full Text
3. ↵
   Schiff D. Single brain metastasis. Curr Treat Options Neurol 2001;3:89–99
4. ↵
   Giese A, Westphal M. Treatment of malignant glioma: a problem beyond the margins of resection. J Cancer Res Clin Oncol 2001;127:217–25

   CrossRefPubMedWeb of Science
5. ↵
   O'Neill BP, Buckner JC, Coffey RJ, et al. Brain metastatic lesions. Mayo Clin Proc 1994;69:1062–68

   PubMed
6. ↵
   Yuh WT, Tali ET, Nguyen HD, et al. The effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis. AJNR Am J Neuroradiol 1995;16:373–80

   Abstract/FREE Full Text
7. ↵
   Wesseling P, Ruiter DJ, Burger PC. Angiogenesis in brain tumors; pathobiological and clinical aspects. J Neurooncol 1997;32:253–65

   CrossRefPubMed
8. ↵
   Jinnouchi T, Shibata S, Fukushima M, et al. Ultrastructure of capillary permeability in human brain tumor–Part 6: Metastatic brain tumor with brain edema [in Japanese]. No Shinkei Geka 1988;16:563–68

   PubMed
9. ↵
   Long DM. Capillary ultrastructure in human metastatic brain tumors. J Neurosurg 1979;51:53–58

   PubMedWeb of Science
10. ↵
    Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994;191:41–51

    PubMedWeb of Science
11. ↵
    Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999;211:791–98

    CrossRefPubMedWeb of Science
12. ↵
    Sugahara T, Korogi Y, Kochi M, et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 1998;171:1479–86

    CrossRefPubMedWeb of Science
13. ↵
    Lev MH, Ozsunar Y, Henson JW, et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. AJNR Am J Neuroradiol 2004;25:214–21

    Abstract/FREE Full Text
14. ↵
    Heiland S, Benner T, Debus J, et al. Simultaneous assessment of cerebral hemodynamics and contrast agent uptake in lesions with disrupted blood-brain-barrier. Magn Reson Imaging 1999;17:21–27

    CrossRefPubMed
15. ↵
    Law M, Yang S, Babb JS, et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 2004;25:746–55

    Abstract/FREE Full Text
16. Li KL, Zhu XP, Checkley DR, et al. Simultaneous mapping of blood volume and endothelial permeability surface area product in gliomas using iterative analysis of first-pass dynamic contrast enhanced MRI data. Br J Radiol 2003;76:39–50

    Abstract/FREE Full Text
17. Provenzale JM, Wang GR, Brenner T, et al. Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. AJR Am J Roentgenol 2002;178:711–16

    CrossRefPubMedWeb of Science
18. ↵
    Roberts HC, Roberts TP, Bollen AW, et al. Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumors. Acad Radiol 2001;8:384–91

    CrossRefPubMed
19. ↵
    Lupo JM, Cha S, Chang SM, et al. Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: characterization of spatial heterogeneity. AJNR Am J Neuroradiol 2005;26:1446–54

    Abstract/FREE Full Text
20. ↵
    Cha S, Lu S, Johnson G, et al. Dynamic susceptibility contrast MR imaging: correlation of signal intensity changes with cerebral blood volume measurements. J Magn Reson Imaging 2000;11:114–19

    CrossRefPubMed
21. ↵
    Rueckert D, Frangi AF, Schnabel JA. Automatic construction of 3-D statistical deformation models of the brain using nonrigid registration. IEEE Trans Med Imaging 2003;22:1014–25

    CrossRefPubMedWeb of Science
22. ↵
    Studholme C, Novotny E, Zubal IG, et al. Estimating tissue deformation between functional images induced by intracranial electrode implantation using anatomical MRI. Neuroimage 2001;13:561–76

    PubMedWeb of Science
23. ↵
    Law M, Cha S, Knopp EA, et al. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 2002;222:715–21

    PubMedWeb of Science
24. ↵
    Kelly PJ, Daumas-Duport C, Scheithauer BE, et al. Stereotactic histologic correlations of computed tomography and magnetic resonance imaging defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 1987;62:450–59

    CrossRefPubMedWeb of Science
25. ↵
    Strugar J, Rothbart D, Harrington W, et al. Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis. J Neurosurg 1994;81:560–66

    CrossRefPubMedWeb of Science
26. ↵
    Rojiani AM, Dorovini-Zis K. Glomeruloid vascular structures in glioblastoma multiforme: an immunohistochemical and ultrastructural study. J Neurosurg 1996;85:1078–84

    PubMedWeb of Science